Airship AI Holdings heads into the back half of May caught between two forces: a founder-CEO who won't stop buying his own stock at lower prices, and a short community that just got fresh ammunition from a weak Q1 print and a $100M dilution shelf.
Short positioning is the central story here, and it is not subtle. Short interest has climbed to 21.7% of free float — up from around 19.5% at the start of April — and the pace picked up sharply this week, rising roughly 7.6% in the past five sessions alone. The borrow market tells an equally tight story: availability has compressed to just 12.7%, meaning there is roughly one share available to borrow for every eight already lent out. That level has been consistently sub-20% for weeks, and briefly dipped below 7% in late April. Cost to borrow has crept up alongside it, climbing to 10.6% from under 9% a month ago — a 19% rise in a month that signals sustained demand for new short positions rather than a one-off squeeze event. ORTEX's short score reached 85.0 this week, ranking AISP in the first percentile across its universe — as extreme a short-side positioning signal as the platform produces, and the score has been grinding higher for two consecutive weeks. Days to cover is running at approximately 17 sessions on official FINRA data, putting any hypothetical unwind in slow motion.
The catalyst that lit this week's positioning move arrived on May 11. Q1 results showed EPS of -$0.02 against a -$0.01 estimate, with revenue of $6.35M missing the $6.90M consensus by about 8%. The same day, the company filed a prospectus for a $100M mixed-shelf offering — not a direct offering, but the optionality to dilute is now on the table for a company with a market cap of just over $82M. That combination — a top-line miss plus a shelf larger than the company's entire equity value — handed short sellers a concrete fundamental argument to press their position.
The analyst side is quiet and somewhat stale. Benchmark is the only active name with coverage, having reiterated a Buy at a $6.00 target in November 2024. Roth MKM initiated at Buy in May 2024 with a $12.00 target. Given the current stock price of $2.40, both targets reflect a substantial implied return of over 150% — but neither has been updated in more than six months, limiting their informational value this week. What is worth noting is that the ORTEX EPS surprise rank comes in at the 89th percentile, a sign that relative to expectations, the company has historically over-delivered; this week's miss is therefore somewhat out of character for the print history.
The insider register provides the genuine counterweight to the short thesis. CEO and founder Victor Huang bought 40,000 shares at $2.24 on March 20, following similar open-market purchases in November 2025. President Paul Allen added 100,000 shares at $2.74 in December 2025. A director joined the buying in November as well. Net insider buying over the past 90 days totals 140,000 shares for roughly $364,000 in value. These are not large in absolute terms for an institutional investor, but they are consistent, open-market, at-market purchases by the CEO at prices close to current levels — a different signal from RSU grants or formulaic 10b5-1 plans. On the institutional side, Derek Xu — the company's largest holder at 15.2% — reduced his position by over 2 million shares in April, while Victor Huang modestly added. That divergence between the two largest holders is notable context.
Earnings history adds one further data point. The two confirmed post-earnings reactions in the dataset both saw the stock fall on the day — down 3.2% and 0.7% respectively — with the five-day moves more pronounced: -4.8% and -7.0%. The most recent result (May 8's quarterly call) produced a -3.2% one-day move, in line with that pattern. The stock is now trading at $2.40, off 5.9% on the week and down 17% year-to-date, while the May 15 after-market session placed it in a screen of the 12 most actively moving IT names.
With availability pinned below 15%, a short score at multi-month highs, and the shelf offering creating an overhang on any attempted recovery rally, the next variable to watch is whether the CEO's open-market buying or the dilution optionality from the shelf offering dictates the stock's next directional move.
See the live data behind this article on ORTEX.
Open AISP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
